Cancer management startups Thyme Care, Jasper Health court employers
As value-based care models continue to gain traction, executives and investors are looking for ways to apply its principles to cancer care.
Why it matters: With cancer costs rising, the $600 billion self-insured employer market is looking for cost containment tools.
Driving the news: Thyme Care, a Nashville-based VBC oncology management platform, this week raised $60 million in Series B funding co-led by Town Hall Ventures and Foresite Capital.
- Proceeds will help Thyme expand into the self-insured employer market next year, and continue to scale after inking a partnership with a large unnamed national health plan, Thyme Care CEO Robin Shah tells Axios.
- At $83 million total raised, Thyme has taken in enough capital to approach "the path to profitability," but is prioritizing growth over that milestone, Shah adds.
What they're saying: Investors in Thyme Care and the leaders of other cancer startups say employers are increasingly looking to reduce costs and turning to the tools they offer as a result.
- "Employers are realizing the important of taking care of their employees, which ultimately helps with recruitment and retention," says Town Hall Ventures general partner David Whelan.
- Adam Pellegrini, CEO of cancer care navigation startup Jasper Health, says in his recent discussions with investors, "Every single one of them has said they have a thesis around oncology and it is a priority pillar for their investment strategy."
How it works: Thyme's platform connects cancer patients with a care management team via phone, video calls and text messages.
- Members get access to symptom management and urgent care triage, as well as social determinants of health resources, like access to transportation, financial aid, behavioral health, nutrition and housing.
- Thyme works with commercial health plans like AmeriHealth New Jersey; Medicare Advantage health plans like Clover Health; the American Oncology Network; and several unnamed at-risk primary care groups.